To: Importersand Manufacturers of Medicines, Subject: Approval of The Requirements for Good Pharmacovigilance Practices (GVP) in Sudan for Marketing Authorization Holders In reference to the above mentioned subject, and in compliance with the National Policies and Plans of the Republic of Sudan and the National Medicines and Poisons Board (NMPB), which aims to enhance public health by assuring the safety, efficacy and quality of the medicines in the Sudanese market, the Secretariat General of the NMPB had approved The Requirements for Good Pharmacovigilance Practices (GVP) in Sudan for Marketing Authorization Holders. This helps to strengthen the system of follow-up of Adverse Drug Reactions (ADRs), which will result in making medicines safer for the public, therefore importers and manufacturers of medicines are required to: 1. Comply with The Requirements for Good Pharmacovigilance Practices (GVP) in Sudan for Marketing Authorization Holders. 2. To assign a qualified and full-time pharmacist to be responsible for the pharmacovigilance at the institute, with the need to bring the CV to the Pharmacovigilance Center at the NMPB directly or via e-mail (pv.team.24@nmpb.gov.sd)within one month from the date of the announcement. 3. Be committed to reporting of ADRs and summary of Periodic Safety Update Report (PSUR Executive Summary) periodically as described in the requirements. Thank you and best regards. The Secretariat General DOWNLOAD
|